Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing
Description
CONCLUSIONS: Parallel integration of Illumina and nanopore sequencing strategies is a suitable solution to ensure both high-throughput and rapid response to cope with accelerating the surveillance demands of SARS-CoV-2 while also maintaining accuracy